Chrys Kokino

Critic
DISC Type : C

President US Specialty at Accord Healthcare

Far Hills, New Jersey, United States

Overview

Chrys Kokino serves as the President of US Specialty at Accord Healthcare, where he is spearheading an ambitious growth strategy in the U. S. biosimilars market. He holds an MBA from Golden Gate University and has a background in global commercialization from previous leadership roles at Mylan, Sandoz, and Roche.

He is a proponent of patient advocacy and community health awareness. This is demonstrated by his leadership in launching campaigns like "PRO-STATE of Mind, " which encourages open conversations and the importance of early detection for prostate cancer.

He recently led the strategic acquisition of the UDENYCA® (pegfilgrastim-cbqv) business, significantly expanding Accords commercial portfolio and workforce.

Personality Overview

Negotiator

Objective Thinker

Information Seeker

It is very likely that they will negotiate pricing or other important terms.  They like to do things independently and don’t look for support from others. Unless the value is proven by data, they are unlikely to value fancy features.

Topics They Care About

Biosimilar Expansion
He is actively driving Accord BioPharma's "ambitious growth journey" in the U. S. biosimilars space through product launches and strategic acquisitions.
Strategic Acquisitions
He recently led the company's acquisition of the UDENYCA® business from Coherus BioSciences to enhance Accord's portfolio and market position.
Patient Advocacy
Champions health awareness by launching campaigns like "PRO-STATE of Mind" to encourage dialogue and early detection of prostate cancer.

Media Appearances

Chrys has no verified media appearances

Work History

2-2021
President US Specialty at Accord Healthcare
6-2013 - 1-2021
Global Head Biologics and Insulins Commercial at Mylan
1-2010 - 5-2013
Head Global Marketing & Head Commercial Operations Middle East, Turkey, Africa at Sandoz Biopharmaceuticals
11-2007 - 4-2010
Global Strategic Marketing; Life Cycle Leader Anaemia Products at Hoffmann-La Roche
11-2005 - 11-2007
Vice President Anaemia Products at Hoffmann-La Roche

Education

Bachelors from UC Santa Barbara
MBA from Golden Gate University

More Information

Social Presence :

Prographics :

Exp : 21 Location : Far Hills, New Jersey, United States Job Level : N/A Designation : President US Specialty at Accord Healthcare
URL has been copied!

Insights For Selling To Chrys

During A Call Or A Meeting

DO's

  • Don’t forget to mention how you compare to competition on both features and pricing
  • Be ready for penetrating questions and critical examination of your pitch
  • Use phrases like ‘expect X% improvement’, ‘data clearly shows’ etc.

DONT's

  • Don’t rush them till they have clearly gotten all the necessary information
  • Avoid phrases like ‘trust me’, ‘others just love’ etc.
  • Avoid pushing them too much to involve other stakeholders unless it is critical

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Chrys is

  • Proven ROI, pricing and objective proof points are the factors that sway their decision.
  • Will you ever get a clear answer from Chrys

  • They are comfortable saying no if they are convinced that it is the correct decision.

Insights For Deal Planning

    How fast (or slow) will Chrys move?

  • Their decision-making is neither very fast nor very slow, they are somewhere in between.
  • Can Chrys take some risk or not?

  • They can take risks if their analysis shows that it would be worth it.

You And Chrys

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.